BeStock  
Markets › Compare › CLDX vs ZLAB

CLDX vs ZLAB

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
CLDX · Celldex Therapeutics$27.42 ▼ 1.93%
ZLAB · Zai Lab$21.03 ▼ 4.06%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

76101126151176Nov 24, '25May 26, '26Nov 20, '26
  • CLDX +4.2%
  • ZLAB +5.5%

Head to head

MetricCLDXZLAB
Price$27.42$21.03
Change today▼ 1.93%▼ 4.06%
Market cap$2.15B$2.36B
Return, 3 months-32.4%-18.0%
Return, year to date+1.0%+19.2%
Return, 1 year+5.8%+5.0%
P/E (TTM)––
P/B3.34.2
P/E percentile vs own 5y99th15th
Dividend yield––
Revenue growth (YoY, latest qtr)–-6.8%
Net profit growth (YoY)-12.7%-28.3%
Gross margin–54.7%
Operating margin-211,684.8%-61.7%
Net margin-195,608.9%-44.9%
Return on equity-49.5%-30.0%
Analyst target vs. price+145.0%+87.0%
Analyst buy share91%100%
RSI (14)3937
30-day volatility50.5%72.3%
Max drawdown, 1 year-38.9%-34.7%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ZLAB is the largest of the group by market value.
  • CLDX has returned the most over the past year.
  • ZLAB keeps the most profit per dollar of sales.
  • CLDX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top